Wednesday, February 16, 2011 5:50:32 AM
Recent IOR News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:40:42 PM
- Income Opportunity Realty Investors, Inc. Reports Earnings for Quarter Ended December 31, 2023 • Business Wire • 03/22/2024 01:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 09:13:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 08:16:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 10:30:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:47:22 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/14/2023 05:21:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:34:05 PM
- Income Opportunity Realty Investors, Inc. reports Earnings for Quarter Ended September 30, 2023 • Business Wire • 11/09/2023 09:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 07:17:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/18/2023 04:32:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 08:16:35 PM
- Income Opportunity Realty Investors, Inc. reports Earnings for Quarter Ended June 30, 2023 • Business Wire • 08/10/2023 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:23:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 05:25:53 PM
- Income Opportunity Realty Investors, Inc. reports Earnings for Quarter Ended March 31, 2023 • Business Wire • 05/11/2023 09:00:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM